The CIOMS I form ("suspect adverse reaction report") was agreed by the Council for International Organizations of Medical Sciences for reporting single cases between countries. ICH E2A calls it a widely accepted standard, ICH E2D(R1) says it can still be used where the electronic E2B format is not in place, and the FDA accepts it for foreign IND safety reports.
It has four sections:
- I. Reaction information: patient initials, country, date of birth and age, sex, reaction onset, a description of the reaction, and check boxes for patient died, hospitalization, disability and life threatening.
- II. Suspect drug information: the suspect drug with its generic name, daily dose, route, indication, therapy dates and duration, and two questions: did the reaction abate after stopping the drug, and did it reappear after reintroduction?
- III. Concomitant drugs and history: other drugs and their dates (leaving out those used to treat the reaction) and relevant history.
- IV. Manufacturer information: the company's control number, the date the company received the report, the source (study, literature, health professional) and whether it is the initial report or a follow-up.
Open the document on the left to see the layout. Box numbers are as on the form.
The four sections of the CIOMS I form.